The year 2026 has become a landmark for regenerative medicine, as the focus shifts from basic cell production to high-precision engineering. A defining trend in the induced pluripotent stem cells market is the integration of AI-guided differentiation protocols, which monitor the growth of stem cells in real-time to ensure they turn into the exact desired cell type, such as neurons or heart...